Skip to main content

Table 1 Schematic representation of the antibodies added to the different FACS tubes for the determination of GRP78+ clones

From: GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment

Tube 1a controlTube 1bTube 2a controlTube 2b
Anti-CD3-PC5.5Anti-CD3-PC5.5Anti-CD3-PC7Anti-CD3-PC7
Anti-CD4-PC7Anti-CD4-PC7Anti-CD14-KrOAnti-CD14-KrO
Anti-CD8-KrOAnti-CD8-KrOAnti-CD62L-PBAnti-CD62L-PB
Anti-CD56-PEAnti-CD56-PEAnti-CCR7-PEAnti-CCR7-PE
Anti-CD16-AF 750Anti-CD16-AF 750Anti-CD45RA-APC-AF 750Anti-CD45RA-APC-AF 750
Anti-NKG2D-APCAnti-NKG2D-APCAnti-CD45RO-PC5.5Anti-CD45RO-PC5.5
IgG2a-DyLight 488Anti-GRP78-DyLight 488IgG2a-DyLight 488Anti-GRP78-DyLight 488
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us